UK Shares How Its Medtech Regs Already Diverge From The EU: COVID-19 Marks The Start
Executive Summary
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
You may also be interested in...
UK Regulator Puts Energies Into COVID-19 While Other Services May Take Longer
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
UK Reveals How To Access Fast-Track Approval Of Devices During COVID-19 Outbreak
How to quickly get non-CE-marked medical device onto the UK market.
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.